<html>
<head>PUBMED IDs for MST-3</head>
<body bgcolor='#C5F0F2'><h1>MST-3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12966428/'>The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.</a> September 11  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/26022559/'>MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells.</a> April 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26022158/'>MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-κB pathway.</a> April 7  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26022148/'>βA3/A1-crystallin and persistent fetal vasculature (PFV) disease of the eye.</a> June 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26022133/'>Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.</a> June 21  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26178994/'>The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle.</a> December 15  2015<br></body></html>
